Inflammatory Bowel Disease (IBD) Clinical Trials

35 recruiting

Inflammatory Bowel Disease (IBD) Trials at a Glance

31 actively recruiting trials for inflammatory bowel disease (ibd) are listed on ClinicalTrialsFinder across 6 cities in 21 countries. The largest study group is Not Applicable with 10 trials, with the heaviest enrollment activity in New York, Cincinnati, and Miami. Lead sponsors running inflammatory bowel disease (ibd) studies include TIDHI Innovation Inc., Asian Institute of Gastroenterology, India, and Artialis.

Browse inflammatory bowel disease (ibd) trials by phase

Treatments under study

About Inflammatory Bowel Disease (IBD) Clinical Trials

Looking for clinical trials for Inflammatory Bowel Disease (IBD)? There are currently 35 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Inflammatory Bowel Disease (IBD) trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Inflammatory Bowel Disease (IBD) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 31 trials

Recruiting
Phase 2

Study of DISC-0974-201 in Participants With IBD and Anemia

AnemiaInflammatory Bowel Disease (IBD)Inflammatory Bowel Disease (IBD); Anemia
Disc Medicine, Inc21 enrolled8 locationsNCT07368972
Recruiting
Phase 1

A Phase 1 Study of PVT401 in Healthy Subjects

Inflammatory Bowel Disease (IBD)
Parvus Therapeutics, Inc.36 enrolled1 locationNCT07423000
Recruiting

Zymfentra (Infliximab-dyyb) REal World Cohort STudy

Ulcerative Colitis (UC)Inflammatory Bowel Disease (IBD)Indeterminate Colitis+1 more
University of North Carolina, Chapel Hill200 enrolled5 locationsNCT07237516
Recruiting
Phase 2

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

Crohn's DiseaseUlcerative Colitis (UC)Inflammatory Bowel Disease (IBD)
Mirador Therapeutics, Inc.140 enrolled66 locationsNCT07113522
Recruiting
Not Applicable

Elemental 028 Extra Case Studies

MalabsorptionAllergiesGastrointestinal Disease+3 more
Nutricia UK Ltd30 enrolled1 locationNCT06877923
Recruiting

Switching to the IL-23 Inhibitor Guselkumab for People With Active IBD Who Previously Used Ustekinumab (SHIFT-IBD)

Ulcerative Colitis (UC)Crohn Disease (CD)Inflammatory Bowel Disease (IBD)+1 more
TIDHI Innovation Inc.200 enrolled9 locationsNCT07245394
Recruiting

Prophylactic Dexamethasone Before Infliximab in Moderate-to-Severe IBD

Inflammatory Bowel Disease (IBD)CD - Crohn's DiseaseUC - Ulcerative Colitis
Second Affiliated Hospital, School of Medicine, Zhejiang University300 enrolled1 locationNCT07385131
Recruiting
Not Applicable

Setting up a Cohort of Patients With Inflammatory Bowel Disease and a Cohort of Patients Without Chronic Inflammatory Bowel Disease

Inflammatory Bowel Disease (IBD)
Artialis120 enrolled1 locationNCT06502873
Recruiting
Not Applicable

Efficacy of Individualized Aerobic Exercise Training in Patients With Inflammatory Bowel Disease

Inflammatory Bowel Disease (IBD)
Ningbo Medical Center Lihuili Hospital28 enrolled1 locationNCT06804733
Recruiting
Not Applicable

Evaluation of the SMART IBD App in Pediatric IBD

IBD (Inflammatory Bowel Disease)Inflammatory Bowel Disease (IBD)
Children's Hospital Medical Center, Cincinnati70 enrolled1 locationNCT07195123
Recruiting

Assessment and Educational Intervention to Reduce Ultra-processed Food Consumption in Pediatric Patients With IBD

Ulcerative Colitis (UC)Crohn Disease (CD)Inflammatory Bowel Disease (IBD)+4 more
Connecticut Children's Medical Center120 enrolled1 locationNCT07224113
Recruiting

A Study of Vedolizumab SC Given to Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease in South Korea

Crohn's DiseaseUlcerative ColitisInflammatory Bowel Disease (IBD)
Takeda600 enrolled1 locationNCT05428345
Recruiting

Microplastic Analysis in Pediatric Inflammatory Bowel Disease

Crohn DiseaseUlcerative Colitis (UC)Inflammatory Bowel Disease (IBD)+1 more
Medical University of Gdansk40 enrolled1 locationNCT07141238
Recruiting
Not Applicable

Pilot Study Assessing the Feasibility and Impact of a Remote Adapted Physical Activity Program on Quality of Life in Patients With Inflammatory Bowel Disease (IBD)

Inflammatory Bowel Disease (IBD)Inflammatory Bowel Disease (Crohn&Amp;#39;s Disease and Ulcerative Colitis)
Raincy Montfermeil Hospital Group72 enrolled2 locationsNCT07191106
Recruiting

Argentine Registry of Crohn's Disease and Ulcerative Colitis

Inflammatory Bowel Disease (IBD)EpidemiologyTherapy
Grupo Argentino de Enfermedad de Crohn y Colitis Ulcerosa4,250 enrolled1 locationNCT07155148
Recruiting

Omics-driven Research on the Gut-Oral Microbiome, Metabolome, Lifestyle, and Clinical Integration in Korean Inflammatory Bowel Disease

Inflammatory Bowel Disease (IBD)
Chang Kyun Lee900 enrolled1 locationNCT06124833
Recruiting
Not Applicable

TIDHI Mental Health in IBD Patients Study

Ulcerative Colitis (UC)Crohn Disease (CD)Inflammatory Bowel Disease (IBD)
TIDHI Innovation Inc.100 enrolled1 locationNCT07013578
Recruiting
Not Applicable

Comparing Diagnostic Accuracy of High-end Intestinal Ultrasound Versus Mid-end Ultrasound With Tandem Ileo-colonoscopy in Inflammatory Bowel Disease : a Paired, Validating Confirmatory Study

Inflammatory Bowel Disease (IBD)
Asian Institute of Gastroenterology, India500 enrolled1 locationNCT06938295
Recruiting
Not Applicable

Fermented Vegan Optimized Diet in Health and Colitis

Healthy VolunteersInflammatory Bowel Disease (IBD)
Region Skane240 enrolled2 locationsNCT06696222
Recruiting

Evaluation of Intestinal Lesions and Disease Activity in Inflammatory Bowel Disease Based on 18F-FAPI PET Imaging

FAPIInflammatory Bowel Disease (IBD)Disease Activity
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University30 enrolled1 locationNCT06945549